Publications

Found 27 results
Filters: Author is Y.L. Liu  [Clear All Filters]
2016
J. Yang, Liu, Y. L., Feng, C. S., Zhu, G. Q., Yang, J., Liu, Y. L., Feng, C. S., and Zhu, G. Q., “Applying the Fisher score to identify Alzheimer's disease-related genes”, vol. 15, p. -, 2016.
J. Yang, Liu, Y. L., Feng, C. S., Zhu, G. Q., Yang, J., Liu, Y. L., Feng, C. S., and Zhu, G. Q., “Applying the Fisher score to identify Alzheimer's disease-related genes”, vol. 15, p. -, 2016.
Y. W. Pan, Zhou, Z. G., Wang, M., Dong, J. Q., Du, K. P., Li, S., Liu, Y. L., Lv, P. J., Gao, J. B., Pan, Y. W., Zhou, Z. G., Wang, M., Dong, J. Q., Du, K. P., Li, S., Liu, Y. L., Lv, P. J., and Gao, J. B., “Combination of IL-6, IL-10, and MCP-1 with traditional serum tumor markers in lung cancer diagnosis and prognosis”, vol. 15, no. 4, p. -, 2016.
Conflicts of interest The authors declare no conflict of interest. ACKNOWLEDGMENTS Research supported by the National Natural Science Fund of China (Grant #81301220). REFERENCES Bhora FY, Chen DJ, Detterbeck FC, et al. (2014). The ITMIG/IASLC thymic epithelial tumors staging project: a proposed lymph node map for thymic epithelial tumors in the forthcoming 8th edition of the TNM classification of malignant tumors. J. Thorac. Oncol. 9: S88-96. Burns TF, Stabile LP, et al (2014). Targeting the estrogen pathway for the treatment and prevention of lung cancer. Lung Cancer Manag. 3: 43-52. http://dx.doi.org/10.2217/lmt.13.67 Chen F, Yan CE, Li J, Han XH, et al (2015a). Diagnostic value of CYFRA 21-1 and CEA for predicting lymph node metastasis in operable lung cancer. Int. J. Clin. Exp. Med. 8: 9820-9824. Chen Y, Zhang F, Tsai Y, Yang X, et al (2015b). IL-6 signaling promotes DNA repair and prevents apoptosis in CD133+ stem-like cells of lung cancer after radiation. Radiat. Oncol. 10: 227. http://dx.doi.org/10.1186/s13014-015-0534-1 Fiala O, Pesek M, Finek J, Svaton M, et al (2016). Prognostic significance of serum tumor markers in patients with advanced-stage NSCLC treated with pemetrexed-based chemotherapy. Anticancer Res. 36: 461-466. Genestreti G, Grossi F, Genova C, Burgio MA, et al (2014). Third- and further-line therapy in advanced non-small-cell lung cancer patients: an overview. Future Oncol. 10: 2081-2096. http://dx.doi.org/10.2217/fon.14.96 Hu L, Ibrahim S, Liu C, Skaar J, et al (2009). Thrombin induces tumor cell cycle activation and spontaneous growth by down-regulation of p27Kip1, in association with the up-regulation of Skp2 and MiR-222. Cancer Res. 69: 3374-3381. http://dx.doi.org/10.1158/0008-5472.CAN-08-4290 Huang Z, Yi X, Luo B, Zhu J, et al (2016). Induced sputum deposition improves diagnostic yields of pulmonary alveolar proteinosis: A clinicopathological and methodological study of 17 cases. Ultrastruct. Pathol. 40: 7-13. http://dx.doi.org/10.3109/01913123.2015.1104404 Lan X, Lan T, Faxiang Q, et al (2015). Interleukin-10 promoter polymorphism and susceptibility to lung cancer: a systematic review and meta-analysis. Int. J. Clin. Exp. Med. 8: 15317-15328. Ma L, Xie XW, Wang HY, Ma LY, et al (2015). Clinical evaluation of tumor markers for diagnosis in patients with non-small cell lung cancer in China. Asian Pac. J. Cancer Prev. 16: 4891-4894. http://dx.doi.org/10.7314/APJCP.2015.16.12.4891 Northcott PA, Fernandez-L A, Hagan JP, Ellison DW, et al (2009). The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res. 69: 3249-3255. http://dx.doi.org/10.1158/0008-5472.CAN-08-4710 Ortakoylu MG, Iliaz S, Bahadir A, Aslan A, et al (2015). Diagnostic value of endobronchial ultrasound-guided transbronchial needle aspiration in various lung diseases. J. Bras. Pneumol. 41: 410-414. http://dx.doi.org/10.1590/S1806-37132015000004493 Pang JC, Kwok WK, Chen Z, Ng HK, et al (2009). Oncogenic role of microRNAs in brain tumors. Acta Neuropathol. 117: 599-611. http://dx.doi.org/10.1007/s00401-009-0525-0 Qader AA, Urraca J, Torsetnes SB, Tønnesen F, et al (2014). Peptide imprinted receptors for the determination of the small cell lung cancer associated biomarker progastrin releasing peptide. J. Chromatogr. A 1370: 56-62. http://dx.doi.org/10.1016/j.chroma.2014.10.023 Reddy SP, Natarajan V, Dudek AZ, et al (2014). MARCKS is marked in combating lung cancer growth and acquired resistance. Am. J. Respir. Crit. Care Med. 190: 1084-1086. http://dx.doi.org/10.1164/rccm.201410-1922ED Sasaki S, Yoshioka Y, Ko R, Katsura Y, et al (2016). Diagnostic significance of cerebrospinal fluid EGFR mutation analysis for leptomeningeal metastasis in non-small-cell lung cancer patients harboring an active EGFR mutation following gefitinib therapy failure. Respir. Investig. 54: 14-19. http://dx.doi.org/10.1016/j.resinv.2015.07.001 Shi P, Meng X, Ni M, Sun X, et al (2015). Association between serum tumor markers and metabolic tumor volume or total lesion glycolysis in patients with recurrent small cell lung cancer. Oncol. Lett. 10: 3123-3128. Shinke H, Masuda S, Togashi Y, Ikemi Y, et al (2015). Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients. Cancer Chemother. Pharmacol. 76: 989-996. http://dx.doi.org/10.1007/s00280-015-2880-y Xiao H, Liu Y, Tan H, Liang P, et al (2015). A pilot study using low-dose Spectral CT and ASIR (Adaptive Statistical Iterative Reconstruction) algorithm to diagnose solitary pulmonary nodules. BMC Med. Imaging 15: 54. http://dx.doi.org/10.1186/s12880-015-0096-6 Yang J, Wei F, Schafer C, Wong DT, et al (2014). Detection of tumor cell-specific mRNA and protein in exosome-like microvesicles from blood and saliva. PLoS One 9: e110641. http://dx.doi.org/10.1371/journal.pone.0110641 Yang L, Shi GL, Song CX, Xu SF, et al (2010). Relationship between genetic polymorphism of MCP-1 and non-small-cell lung cancer in the Han nationality of North China. Genet. Mol. Res. 9: 765-771. http://dx.doi.org/10.4238/vol9-2gmr740 Zaric B, Stojsic V, Carapic V, Kovacevic T, et al (2016). Radial endobronchial ultrasound (EBUS) guided suction catheter-biopsy in histological diagnosis of peripheral pulmonary lesions. J. Cancer 7: 7-13. http://dx.doi.org/10.7150/jca.13081 Zhao K, Xu J, Tian H, et al (2016). Correlation analysis between an IL-6 genetic polymorphism and non-small cell lung cancer prognosis. Genet. Mol. Res. 15: 15017021. http://dx.doi.org/10.4238/gmr.15017021
Y. W. Pan, Zhou, Z. G., Wang, M., Dong, J. Q., Du, K. P., Li, S., Liu, Y. L., Lv, P. J., Gao, J. B., Pan, Y. W., Zhou, Z. G., Wang, M., Dong, J. Q., Du, K. P., Li, S., Liu, Y. L., Lv, P. J., and Gao, J. B., “Combination of IL-6, IL-10, and MCP-1 with traditional serum tumor markers in lung cancer diagnosis and prognosis”, vol. 15, no. 4, p. -, 2016.
Conflicts of interest The authors declare no conflict of interest. ACKNOWLEDGMENTS Research supported by the National Natural Science Fund of China (Grant #81301220). REFERENCES Bhora FY, Chen DJ, Detterbeck FC, et al. (2014). The ITMIG/IASLC thymic epithelial tumors staging project: a proposed lymph node map for thymic epithelial tumors in the forthcoming 8th edition of the TNM classification of malignant tumors. J. Thorac. Oncol. 9: S88-96. Burns TF, Stabile LP, et al (2014). Targeting the estrogen pathway for the treatment and prevention of lung cancer. Lung Cancer Manag. 3: 43-52. http://dx.doi.org/10.2217/lmt.13.67 Chen F, Yan CE, Li J, Han XH, et al (2015a). Diagnostic value of CYFRA 21-1 and CEA for predicting lymph node metastasis in operable lung cancer. Int. J. Clin. Exp. Med. 8: 9820-9824. Chen Y, Zhang F, Tsai Y, Yang X, et al (2015b). IL-6 signaling promotes DNA repair and prevents apoptosis in CD133+ stem-like cells of lung cancer after radiation. Radiat. Oncol. 10: 227. http://dx.doi.org/10.1186/s13014-015-0534-1 Fiala O, Pesek M, Finek J, Svaton M, et al (2016). Prognostic significance of serum tumor markers in patients with advanced-stage NSCLC treated with pemetrexed-based chemotherapy. Anticancer Res. 36: 461-466. Genestreti G, Grossi F, Genova C, Burgio MA, et al (2014). Third- and further-line therapy in advanced non-small-cell lung cancer patients: an overview. Future Oncol. 10: 2081-2096. http://dx.doi.org/10.2217/fon.14.96 Hu L, Ibrahim S, Liu C, Skaar J, et al (2009). Thrombin induces tumor cell cycle activation and spontaneous growth by down-regulation of p27Kip1, in association with the up-regulation of Skp2 and MiR-222. Cancer Res. 69: 3374-3381. http://dx.doi.org/10.1158/0008-5472.CAN-08-4290 Huang Z, Yi X, Luo B, Zhu J, et al (2016). Induced sputum deposition improves diagnostic yields of pulmonary alveolar proteinosis: A clinicopathological and methodological study of 17 cases. Ultrastruct. Pathol. 40: 7-13. http://dx.doi.org/10.3109/01913123.2015.1104404 Lan X, Lan T, Faxiang Q, et al (2015). Interleukin-10 promoter polymorphism and susceptibility to lung cancer: a systematic review and meta-analysis. Int. J. Clin. Exp. Med. 8: 15317-15328. Ma L, Xie XW, Wang HY, Ma LY, et al (2015). Clinical evaluation of tumor markers for diagnosis in patients with non-small cell lung cancer in China. Asian Pac. J. Cancer Prev. 16: 4891-4894. http://dx.doi.org/10.7314/APJCP.2015.16.12.4891 Northcott PA, Fernandez-L A, Hagan JP, Ellison DW, et al (2009). The miR-17/92 polycistron is up-regulated in sonic hedgehog-driven medulloblastomas and induced by N-myc in sonic hedgehog-treated cerebellar neural precursors. Cancer Res. 69: 3249-3255. http://dx.doi.org/10.1158/0008-5472.CAN-08-4710 Ortakoylu MG, Iliaz S, Bahadir A, Aslan A, et al (2015). Diagnostic value of endobronchial ultrasound-guided transbronchial needle aspiration in various lung diseases. J. Bras. Pneumol. 41: 410-414. http://dx.doi.org/10.1590/S1806-37132015000004493 Pang JC, Kwok WK, Chen Z, Ng HK, et al (2009). Oncogenic role of microRNAs in brain tumors. Acta Neuropathol. 117: 599-611. http://dx.doi.org/10.1007/s00401-009-0525-0 Qader AA, Urraca J, Torsetnes SB, Tønnesen F, et al (2014). Peptide imprinted receptors for the determination of the small cell lung cancer associated biomarker progastrin releasing peptide. J. Chromatogr. A 1370: 56-62. http://dx.doi.org/10.1016/j.chroma.2014.10.023 Reddy SP, Natarajan V, Dudek AZ, et al (2014). MARCKS is marked in combating lung cancer growth and acquired resistance. Am. J. Respir. Crit. Care Med. 190: 1084-1086. http://dx.doi.org/10.1164/rccm.201410-1922ED Sasaki S, Yoshioka Y, Ko R, Katsura Y, et al (2016). Diagnostic significance of cerebrospinal fluid EGFR mutation analysis for leptomeningeal metastasis in non-small-cell lung cancer patients harboring an active EGFR mutation following gefitinib therapy failure. Respir. Investig. 54: 14-19. http://dx.doi.org/10.1016/j.resinv.2015.07.001 Shi P, Meng X, Ni M, Sun X, et al (2015). Association between serum tumor markers and metabolic tumor volume or total lesion glycolysis in patients with recurrent small cell lung cancer. Oncol. Lett. 10: 3123-3128. Shinke H, Masuda S, Togashi Y, Ikemi Y, et al (2015). Urinary kidney injury molecule-1 and monocyte chemotactic protein-1 are noninvasive biomarkers of cisplatin-induced nephrotoxicity in lung cancer patients. Cancer Chemother. Pharmacol. 76: 989-996. http://dx.doi.org/10.1007/s00280-015-2880-y Xiao H, Liu Y, Tan H, Liang P, et al (2015). A pilot study using low-dose Spectral CT and ASIR (Adaptive Statistical Iterative Reconstruction) algorithm to diagnose solitary pulmonary nodules. BMC Med. Imaging 15: 54. http://dx.doi.org/10.1186/s12880-015-0096-6 Yang J, Wei F, Schafer C, Wong DT, et al (2014). Detection of tumor cell-specific mRNA and protein in exosome-like microvesicles from blood and saliva. PLoS One 9: e110641. http://dx.doi.org/10.1371/journal.pone.0110641 Yang L, Shi GL, Song CX, Xu SF, et al (2010). Relationship between genetic polymorphism of MCP-1 and non-small-cell lung cancer in the Han nationality of North China. Genet. Mol. Res. 9: 765-771. http://dx.doi.org/10.4238/vol9-2gmr740 Zaric B, Stojsic V, Carapic V, Kovacevic T, et al (2016). Radial endobronchial ultrasound (EBUS) guided suction catheter-biopsy in histological diagnosis of peripheral pulmonary lesions. J. Cancer 7: 7-13. http://dx.doi.org/10.7150/jca.13081 Zhao K, Xu J, Tian H, et al (2016). Correlation analysis between an IL-6 genetic polymorphism and non-small cell lung cancer prognosis. Genet. Mol. Res. 15: 15017021. http://dx.doi.org/10.4238/gmr.15017021
L. J. Ding, Liu, Y. L., Ma, G., Jia, Y. Q., Wei, Y. S. H., Liu, X. M., Ding, L. J., Liu, Y. L., Ma, G., Jia, Y. Q., Wei, Y. S. H., and Liu, X. M., “Correlation of acetabular chondrocyte apoptosis with caspase-3 and Bcl-2 expression in developmental dislocations of the hip”, vol. 15, p. -, 2016.
L. J. Ding, Liu, Y. L., Ma, G., Jia, Y. Q., Wei, Y. S. H., Liu, X. M., Ding, L. J., Liu, Y. L., Ma, G., Jia, Y. Q., Wei, Y. S. H., and Liu, X. M., “Correlation of acetabular chondrocyte apoptosis with caspase-3 and Bcl-2 expression in developmental dislocations of the hip”, vol. 15, p. -, 2016.
S. Chen, Zhu, X. C., Liu, Y. L., Wang, C., Zhang, K. G., Chen, S., Zhu, X. C., Liu, Y. L., Wang, C., and Zhang, K. G., “Investigating the association between XRCC1 gene polymorphisms and susceptibility to gastric cancer”, vol. 15, p. -, 2016.
S. Chen, Zhu, X. C., Liu, Y. L., Wang, C., Zhang, K. G., Chen, S., Zhu, X. C., Liu, Y. L., Wang, C., and Zhang, K. G., “Investigating the association between XRCC1 gene polymorphisms and susceptibility to gastric cancer”, vol. 15, p. -, 2016.
M. Zhao, Li, C. H., Liu, Y. L., Zhao, M., Li, C. H., Liu, Y. L., Zhao, M., Li, C. H., and Liu, Y. L., “Toll-like receptor (TLR)-2/4 expression in retinal ganglion cells in a high-glucose environment and its implications”, vol. 15, p. -, 2016.
M. Zhao, Li, C. H., Liu, Y. L., Zhao, M., Li, C. H., Liu, Y. L., Zhao, M., Li, C. H., and Liu, Y. L., “Toll-like receptor (TLR)-2/4 expression in retinal ganglion cells in a high-glucose environment and its implications”, vol. 15, p. -, 2016.
M. Zhao, Li, C. H., Liu, Y. L., Zhao, M., Li, C. H., Liu, Y. L., Zhao, M., Li, C. H., and Liu, Y. L., “Toll-like receptor (TLR)-2/4 expression in retinal ganglion cells in a high-glucose environment and its implications”, vol. 15, p. -, 2016.
2015
Y. C. Fan, Min, L., Chen, H., and Liu, Y. L., “Alternative splicing isoform of T cell factor 4K suppresses the proliferation and metastasis of non-small cell lung cancer cells”, vol. 14, pp. 14009-14018, 2015.
H. C. Qu, Zhang, W., Liu, Y. L., and Wang, P., “Association between polymorphism of β3-adrenoceptor gene and overactive bladder: a meta-analysis”, vol. 14, pp. 2495-2501, 2015.
X. M. Wang, Shi, K., Li, J. J., Chen, T. T., Guo, Y. H., Liu, Y. L., Yang, Y. F., and Yang, S., “Effects of angiotensin II intervention on MMP-2, MMP-9, TIMP-1, and collagen expression in rats with pulmonary hypertension”, vol. 14, pp. 1707-1717, 2015.
L. Zhang, Zhang, Z. H., Shen, F. J., Hou, R., Zhang, W. P., Liu, Y. L., Tu, K. Y., and Yang, A. L., “Identification and characterization of polymorphic microsatellite loci in the red-crowned crane”, vol. 14, pp. 15169-15176, 2015.
W. C. Li, Ji, S. D., Wang, X. C., Li, Z. K., Zhang, H. C., Tian, C. Z., Liu, Y. L., and Duan, C. X., “Ion beam transformation with corn DNA alters proteinase expression in rice seedling roots”, vol. 14, pp. 7258-7266, 2015.
J. Q. Li, Wang, L. H., Zhan, Q. W., Liu, Y. L., Zhang, Q., Li, J. F., and Fan, F. F., “Mapping quantitative trait loci for five forage quality traits in a sorghum-sudangrass hybrid”, vol. 14, pp. 13266-13273, 2015.
Y. L. Liu, Wang, L. H., Li, J. Q., Zhan, Q. W., Zhang, Q., Li, J. F., and Fan, F. F., “QTL mapping of forage yield and forage yield component traits in Sorghum bicolor x S. sudanense”, vol. 14, pp. 3854-3861, 2015.
Y. Li, Wang, L., Zhang, L. Y., Liu, Y. L., Jiang, Z. Y., Cai, R. J., and Song, C. X., “Serum cytokine modulation after Staphylococcus hyicus infection in BALB/c mice”, vol. 14, pp. 16682-16693, 2015.
2014
X. J. Zhang, Wang, L. X., Chen, X. X., Liu, Y. L., Meng, R., Wang, Y. J., and Zhao, Z. Y., “A and MdMYB1 allele-specific markers controlling apple (Malus x domestica Borkh.) skin color and suitability for marker-assisted selection”, vol. 13, pp. 9103-9114, 2014.
L. Gao, Zhang, J. P., Chen, H., Zhang, S. N., Chen, L. B., Tan, J. P., Liu, M. L., Meng, L. L., Wang, Y. H., Zhang, R., Liu, Y. L., and Cai, W. B., “Characteristics of immune cell changes before and after immunotherapy and their clinical significance in patients with unexplained recurrent spontaneous abortion”, vol. 13, pp. 1169-1178, 2014.
L. Gao, Zhang, J. P., Chen, H., Guo, Z. J., Chen, L. B., Tan, J. P., Wang, Y. H., Zhang, R., Liu, Y. L., and Cai, W. B., “Fetal fibronectin detection for preterm birth prediction”, vol. 13, pp. 1323-1328, 2014.
H. Zhang, Lu, L. Z., Chen, L., Tao, Z. R., Chen, F., Zhong, S. L., Liu, Y. L., Tian, Y., and Yan, P. S., “Molecular cloning, expression, and regulation of the ovalbumin gene in pigeon oviduct epithelial cells”, vol. 13, pp. 117-126, 2014.
H. C. Qu, Yan, S., Zhang, X. L., Zhu, X. W., Liu, Y. L., and Wang, P., “Urinary nerve growth factor levels could be a biomarker for overactive bladder symptom: a meta-analysis”, vol. 13, pp. 8609-8619, 2014.
2013
Y. L. Liu, Zhong, L. X., Li, J. J., Shen, J. D., Wang, D. Q., Tao, Z. R., Shi, F. X., and Lu, L. Z., “Construction and analysis of a subtractive cDNA library of early embryonic development in duck”, vol. 12, pp. 2234-2247, 2013.
S. Yan, Li, Y. Z., Zhu, X. W., Liu, C. L., Wang, P., and Liu, Y. L., “HuGE systematic review and meta-analysis demonstrate association of CASP-3 and CASP-7 genetic polymorphisms with cancer risk”, vol. 12, pp. 1561-1573, 2013.
2012
S. Yan, Li, Y. Z., Zhu, J. W., Liu, C. L., Wang, P., and Liu, Y. L., “Role of CASP-10 gene polymorphisms in cancer susceptibility: a HuGE review and meta-analysis”, vol. 11, pp. 3998-4007, 2012.
Alison MR and Sarraf CE (1992). Apoptosis: a gene-directed programme of cell death. J. R. Coll. Physicians Lond. 26: 25-35. PMid:1315390   Boatright KM and Salvesen GS (2003). Mechanisms of caspase activation. Curr. Opin. Cell Biol. 15: 725-731. http://dx.doi.org/10.1016/j.ceb.2003.10.009 PMid:14644197   Doonan F and Cotter TG (2008). Morphological assessment of apoptosis. Methods 44: 200-204. http://dx.doi.org/10.1016/j.ymeth.2007.11.006 PMid:18314050   Frank B, Hemminki K, Wappenschmidt B, Meindl A, et al. (2006). Association of the CASP10 V410I variant with reduced familial breast cancer risk and interaction with the CASP8 D302H variant. Carcinogenesis 27: 606-609. http://dx.doi.org/10.1093/carcin/bgi248 PMid:16251207   Gaudet MM, Milne RL, Cox A, Camp NJ, et al. (2009). Five polymorphisms and breast cancer risk: results from the Breast Cancer Association Consortium. Cancer Epidemiol. Biomarkers Prev. 18: 1610-1616. http://dx.doi.org/10.1158/1055-9965.EPI-08-0745 PMid:19423537 PMCid:2737177   Ghavami S, Hashemi M, Ande SR, Yeganeh B, et al. (2009). Apoptosis and cancer: mutations within caspase genes. J. Med. Genet. 46: 497-510. http://dx.doi.org/10.1136/jmg.2009.066944 PMid:19505876   Higgins JP and Thompson SG (2002). Quantifying heterogeneity in a meta-analysis. Stat. Med. 21: 1539-1558. http://dx.doi.org/10.1002/sim.1186 PMid:12111919   Hosgood HD, III, Baris D, Zhang Y, Zhu Y, et al. (2008). Caspase polymorphisms and genetic susceptibility to multiple myeloma. Hematol. Oncol. 26: 148-151. http://dx.doi.org/10.1002/hon.852 PMid:18381704 PMCid:2586415   Kim MS, Oh JE, Min CK, Lee S, et al. (2009). Mutational analysis of CASP10 gene in acute leukaemias and multiple myelomas. Pathology 41: 484-487. http://dx.doi.org/10.1080/00313020903041143 PMid:19900088   Kumar S (2004). Measurement of caspase activity in cells undergoing apoptosis. Methods Mol. Biol. 282: 19-30. PMid:15105554   Lan Q, Zheng T, Chanock S, Zhang Y, et al. (2007). Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. Carcinogenesis 28: 823-827. http://dx.doi.org/10.1093/carcin/bgl196 PMid:17071630   Li C, Zhao H, Hu Z, Liu Z, et al. (2008). Genetic variants and haplotypes of the caspase-8 and caspase-10 genes contribute to susceptibility to cutaneous melanoma. Hum. Mutat. 29: 1443-1451. http://dx.doi.org/10.1002/humu.20803 PMid:18563783 PMCid:2937220   MacPherson G, Healey CS, Teare MD, Balasubramanian SP, et al. (2004). Association of a common variant of the CASP8 gene with reduced risk of breast cancer. J. Natl. Cancer Inst. 96: 1866-1869. http://dx.doi.org/10.1093/jnci/dji001 PMid:15601643   Nicholson DW (1996). ICE/CED3-like proteases as therapeutic targets for the control of inappropriate apoptosis. Nat. Biotechnol. 14: 297-301. http://dx.doi.org/10.1038/nbt0396-297 PMid:9630889   Nicholson DW and Thornberry NA (1997). Caspases: killer proteases. Trends Biochem. Sci. 22: 299-306. http://dx.doi.org/10.1016/S0968-0004(97)01085-2   Niles AL, Moravec RA and Riss TL (2008). Caspase activity assays. Methods Mol. Biol. 414: 137-150. PMid:18175817   Oh JE, Kim MS, Ahn CH, Kim SS, et al. (2010). Mutational analysis of CASP10 gene in colon, breast, lung and hepatocellular carcinomas. Pathology 42: 73-76. http://dx.doi.org/10.3109/00313020903434371 PMid:20025484   Park WS, Lee JH, Shin MS, Park JY, et al. (2002). Inactivating mutations of the caspase-10 gene in gastric cancer. Oncogene 21: 2919-2925. http://dx.doi.org/10.1038/sj.onc.1205394 PMid:11973654   Peters JL, Sutton AJ, Jones DR, Abrams KR, et al. (2006). Comparison of two methods to detect publication bias in meta-analysis. JAMA 295: 676-680. http://dx.doi.org/10.1001/jama.295.6.676 PMid:16467236   Rupinder SK, Gurpreet AK and Manjeet S (2007). Cell suicide and caspases. Vascul. Pharmacol. 46: 383-393. http://dx.doi.org/10.1016/j.vph.2007.01.006 PMid:17382599   Shin MS, Kim HS, Kang CS, Park WS, et al. (2002). Inactivating mutations of CASP10 gene in non-Hodgkin lymphomas. Blood 99: 4094-4099. http://dx.doi.org/10.1182/blood.V99.11.4094 PMid:12010812   Ulybina YM, Kuligina ES, Mitiushkina NV, Rozanov ME, et al. (2009). Coding polymorphisms in Casp5, Casp8 and DR4 genes may play a role in predisposition to lung cancer. Cancer Lett. 278: 183-191. http://dx.doi.org/10.1016/j.canlet.2009.01.012 PMid:19203830   von Elm E, Altman DG, Egger M, Pocock SJ, et al. (2007). The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology 18: 800-804. http://dx.doi.org/10.1097/EDE.0b013e3181577654 PMid:18049194   Wang J, Chun HJ, Wong W, Spencer DM, et al. (2001). Caspase-10 is an initiator caspase in death receptor signaling. Proc. Natl. Acad. Sci. U. S. A. 98: 13884-13888. http://dx.doi.org/10.1073/pnas.241358198 PMid:11717445 PMCid:61136   Ye YF (2004). Polymorphisms of Caspase-8, -10 Genes and Their Relationship with Pathogenesis of Non-Hodgkin lymphoma. Master's thesis, Zhejiang University School of Medicine, Zhejiang.   Zhang L, Liu JL, Zhang YJ and Wang H (2011). Association between HLA-B*27 polymorphisms and ankylosing spondylitis in Han populations: a meta-analysis. Clin. Exp. Rheumatol. 29: 285-292. PMid:21418777   Zintzaras E and Ioannidis JP (2005). Heterogeneity testing in meta-analysis of genome searches. Genet. Epidemiol. 28: 123-137. http://dx.doi.org/10.1002/gepi.20048 PMid:15593093